Curious how the Institute for Clinical and Economic Review works? Leslie Isenegger from our Reputation and Risk Management Practice, provides a primer of sorts on ICER, exploring how the organization works to determine cost effectiveness and comparative effectiveness of therapies, the nature of its relationships with payers and pharma companies, the unique challenge of assessing value of orphan drugs, the growing role of the patient in value discussions and more.